Activities per year
Activities
- 4 results
Search results
-
Acquired mutations within the JAK2 kinase domain confer resistance to JAK inhibitors in in vitro models of acute lymphoblastic leukaemia
Downes, C. (Speaker)
Sept 2021Activity: Talk or presentation types › Oral presentation
-
Precision medicine approaches and drug resistance in JAK2-rearranged acute lymphoblastic leukaemia
Downes, C. (Speaker)
2021Activity: Talk or presentation types › Oral presentation
-
Identification of ruxolitinib resistant mutations in Pro-B cells driven by a high-risk JAK2 fusion in B-cell acute lymphoblastic leukaemia
Downes, C. (Speaker)
6 Jun 2018Activity: Talk or presentation types › Oral presentation
-
Identification of ruxolitinib resistance mutations in Pro-B cells driven by a high-risk B-ALL JAK2-fusion
Downes, C. (Speaker)
17 May 2018Activity: Talk or presentation types › Oral presentation